Intracerebroventricular losartan infusion modulates angiotensin II type 1 receptor expression in the subfornical organ and drinking behaviour in bile-duct-ligated rats

Experimental Physiology

Volumn 98, Issue 4, 2013, Pages 922-933

  Walch, Joseph D ^a,b   Carreño, Flávia Regina ^b   Cunningham, J Thomas ^a  

^a UNIVERSITY OF NORTH TEXAS   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; LOSARTAN; MESSENGER RNA; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT LIGATION; DRINKING BEHAVIOR; DRUG INFUSION; FLUID INTAKE; FOOD INTAKE; LIVER CIRRHOSIS; MALE; NONHUMAN; OSMOLALITY; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SUBFORNICAL ORGAN; UPREGULATION; URINE VOLUME; WESTERN BLOTTING;

EID: 84875485898     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2012.068593     Document Type: Article

References (57)

1. Allen AM, Moeller I, Jenkins TA, Zhuo J, Aldred GP, Chai SY & Mendelsohn FAO (1998). Angiotensin receptors in the nervous system. Brain Res Bull 47, 17-28.
2. 1A receptor mRNA within the rat subfornical organ during dehydration. Brain Res Mol Brain Res 64, 151-164.
3. Better OS, Aisenbrey GA, Berl T, Anderson RJ, Handelman WA, Linas SL, Guggenheim SJ & Schrier RW (1980). Role of antidiuretic hormone in impaired urinary dilution associated with chronic bile-duct ligation. Clin Sci (Lond) 58, 493-500.
4. Brond L, Hadrup N, Salling N, Torp M, Graebe M, Christensen S, Nielsen S & Jonassen TE (2004). Uncoupling of vasopressin signaling in collecting ducts from rats with CBL-induced liver cirrhosis. Am J Physiol Renal Physiol 287, F806-F815.
5. Buggy J & Johnson AK (1978). Angiotensin-induced thirst: effects of third ventricle obstruction and periventricular ablation. Brain Res 149, 117-128.
6. Burson JM, Aguilera G, Gross KW & Sigmund CD (1994). Differential expression of angiotensin receptor 1A and 1B in mouse. Am J Physiol Endocrinol Metab 267, E260-E267.
7. Cárdenas A & Arroyo V (2003). Mechanisms of water and sodium retention in cirrhosis and the pathogenesis of ascites. Best Pract Res Clin Endocrinol Metab 17, 607-622.
8. Carreño FR, Ji LL & Cunningham JT (2009). Altered central TRPV4 expression and lipid raft association related to inappropriate vasopressin secretion in cirrhotic rats. Am J Physiol Regul Integr Comp Physiol 296, R454-R466.
9. Cato MJ & Toney GM (2005). Angiotensin II excites paraventricular nucleus neurons that innervate the rostral ventrolateral medulla: an in vitro patch-clamp study in brain slices. J Neurophysiol 93, 403-413.
10. 1-receptor blockade in the hypothalamic PVN reduces central hyperosmolality-induced renal sympathoexcitation. Am J Physiol Regul Integr Comp Physiol 281, R1844-R1853.
11. 1a receptors in mouse brain. Hypertension 47, 230-237.
12. 1 receptors are essentially identical. Biochem Biophys Res Commun 197, 440-449.
13. Croquet V, Moal F, Veal N, Wang J, Oberti F, Roux J, Vuillemin E, Gallois Y, Douay O, Chappard D & Cales P (2002). Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension. J Hepatol 37, 773-780.
14. Davisson RL (2000). Divergent functions of angiotensin II receptor isoforms in the brain. J Clin Invest 106, 103-106.
15. Fitts DA, Lane JR, Starbuck EM & Li CP (1999). Drinking and blood pressure during sodium depletion or ANG II infusion in chronic cholestatic rats. Am J Physiol Regul Integr Comp Physiol 276, R23-R31.
16. Fregly MJ, Paulding W & Rowland NE (1990). Comparison of the dipsogenic responsiveness of Long-Evans and Sprague-Dawley rats. Physiol Behav 47, 1187-1192.
17. 2 receptor blockade with tolvaptan versus fluid restriction in the treatment of hyponatremia. Am J Cardiol 97, 1064-1067.
18. 2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial. Circulation 107, 2690-2696.
19. 1A receptor and Fos protein in forebrain neuronal populations responding to acute hydromineral deficit. Brain Res 996, 81-88.
20. Gutkind JS, Kurihara M, Castren E & Saavedra JM (1988). Increased concentration of angiotensin II binding sites in selected brain areas of spontaneously hypertensive rats. J Hypertens 6, 79-84.
21. Hommel JD, Sears RM, Georgescu D, Simmons DL & DiLeone RJ (2003). Local gene knockdown in the brain using viral-mediated RNA interference. Nat Med 9, 1539-1544.
22. 1 receptors and cardiac dysfunction in rats post-myocardial infarction. Am J Physiol Heart Circ Physiol 297, H968-H975.
23. Hwang BH, Wu JY & Severs WB (1986). Effects of chronic dehydration on angiotensin II receptor binding in the subfornical organ, paraventricular hypothalamic nucleus and adrenal medulla of Long-Evans rats. Neurosci Lett 65, 35-40.
24. Iwai N, Inagami T, Ohmichi N, Nakamura Y, Saeki Y & Kinoshita M (1992). Differential regulation of rat AT1a and AT1b receptor mRNA. Biochem Biophys Res Commun 188, 298-303.
25. Johnson AK (2007). The sensory psychobiology of thirst and salt appetite. Med Sci Sports Exerc 39, 1388-1400.
26. Kim MY, Baik SK & Lee SS (2010). Hemodynamic alterations in cirrhosis and portal hypertension. Korean J Hepatol 16, 347-352.
27. Lane JR, Louie S, Lee P & Fitts DA (1998). Induced preference or conditioned aversion for sodium chloride in rats with chronic bile duct ligation. Physiol Behav 63, 537-543.
28. 1) receptors. Am J Physiol Regul Integr Comp Physiol 295, R1539-R1545.
29. Lind RW, Thunhorst RL & Johnson AK (1984). The subfornical organ and the integration of multiple factors in thirst. Physiol Behav 32, 69-74.
30. Livak KJ & Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the method. Methods 25, 402-408.
31. Llorens-Cortes C, Greenberg B, Huang H & Corvol P (1994). Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis. Hypertension 24, 538-548.
32. McKinley MJ, Denton DA, Oldfield BJ, De Oliveira LB & Mathai ML (2006). Water intake and the neural correlates of the consciousness of thirst. Semin Nephrol 26, 249-257.
33. McKinley MJ & Johnson AK (2004). The physiological regulation of thirst and fluid intake. News Physiol Sci 19, 1-6.
34. McKinley MJ, Mathai ML, McAllen RM, McClear RC, Miselis RR, Pennington GL, Vivas L, Wade JD & Oldfield BJ (2004). Vasopressin secretion: osmotic and hormonal regulation by the lamina terminalis. J Neuroendocrinol 16, 340-347.
35. McKinley MJ, Walker LL, Alexiou T, Allen AM, Campbell DJ, Di Nicolantonio R, Oldfield BJ & Denton DA (2008). Osmoregulatory fluid intake but not hypovolemic thirst is intact in mice lacking angiotensin. Am J Physiol Regul Integr Comp Physiol 294, R1533-R1543.
36. Nazarali AJ, Gutkind JS & Saavedra JM (1987). Regulation of angiotensin II binding sites in the subfornical organ and other rat brain nuclei after water deprivation. Cell Mol Neurobiol 7, 447-455.
37. O'Neill TP & Brody MJ (1987). Role for the median preoptic nucleus in centrally evoked pressor responses. Am J Physiol Regul Integr Comp Physiol 252, R1165-R1172.
38. Oren RM (2005). Hyponatremia in congestive heart failure. Am J Cardiol 95, 2B-7B.
39. Osborn JW, Fink GD, Sved AF, Toney GM & Raizada MK (2007). Circulating angiotensin II and dietary salt: converging signals for neurogenic hypertension. Curr HypertensRep 9, 228-235.
40. 1 receptors enhance inhibitory and excitatory synaptic neurotransmission to motoneurons and other ventral horn neurons in neonatal rat spinal cord. J Neurophysiol 94, 1405-1412.
41. Ozaki Y, Soya A, Nakamura J, Matsumoto T & Ueta Y (2004). Potentiation by angiotensin II of spontaneous excitatory postsynaptic currents in rat supraoptic magnocellular neurones. J Neuroendocrinol 16, 871-879.
42. Paxinos G & Watson C (1997). The Rat Brain in Stereotaxic Coordinates . Academic Press, San Diego .
43. Pérez-Delgado MDM, Carmona-Calero E, Marrero-Gordillo N, Pérez-González H & Castañeyra-Perdomo A (2000). Effect of hypertension on the angiotensin II fibres arriving at the posterior lobe of the hypophysis of the rat. An immunohistochemical study. Histol Histopathol 15, 73-77.
44. Porter JP, Phillips A, Rich J & Wright D (2004). Effect of chronic stress on the cardiac baroreflex in the post-weanling rat. Life Sci 75, 1595-1607.
45. Rossi J, Bayram M, Udelson JE, Lloyd-Jones D, Adams KF, Oconnor CM, Stough WG, Ouyang J, Shin DD, Orlandi C & Gheorghiade M (2007). Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial. Acute Card Care 9, 82-86.
46. Rozen-Zvi B, Yahav D, Gheorghiade M, Korzets A, Leibovici L & Gafter U (2010). Vasopressin receptor antagonists for the treatment of hyponatremia: systematic review and meta-analysis. Am J Kidney Dis 56, 325-337.
47. Sakai K, Agassandian K, Morimoto S, Sinnayah P, Cassell MD, Davisson RL & Sigmund CD (2007). Local production of angiotensin II in the subfornical organ causes elevated drinking. J Clin Invest 117, 1088-1095.
48. Sanvitto GL, Jöhren O, Häuser W & Saavedra JM (1997). Water deprivation upregulates ANG II AT1 binding and mRNA in rat subfornical organ and anterior pituitary. Am J Physiol Endocrinol Metab 273, E156-E163.
49. T method. Nat Protoc 3, 1101-1108.
50. Schrier RW (2006). Water and sodium retention in edematous disorders: role of vasopressin and aldosterone. Am J Med 119, S47-S53.
51. Schrier RW (2010). Primary systemic arterial vasodilation in cirrhotic patients. Kidney Int 78, 619.
52. 2-receptor antagonist, for hyponatremia. N Engl J Med 355, 2099-2112.
53. 1 receptor expression in rats via the mitogen-activated protein kinase pathway. Am J Physiol Heart Circ Physiol 296, H1425-H1433.
54. Wei SG, Yu Y, Zhang ZH, Weiss RM & Felder RB (2008). Mitogen-activated protein kinases mediate upregulation of hypothalamic angiotensin II type 1 receptors in heart failure rats. Hypertension 52, 679-686.
55. Xue B, Beltz TG, Yu Y, Guo F, Gomez-Sanchez CE, Hay M & Johnson AK (2011). Central interactions of aldosterone and angiotensin II in aldosterone- and angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol 300, H555-H564.
56. Yang YY, Lin HC, Huang YT, Lee TY, Hou MC, Lee FY, Liu RS, Chang FY & Lee SD (2002). Effect of 1-week losartan administration on bile duct-ligated cirrhotic rats with portal hypertension. J Hepatol 36, 600-606.
57. Zimmerman MC, Lazartigues E, Sharma RV & Davisson RL (2004). Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res 95, 210-216.